Table 4

Relevant pharmacogenetic association studies that focused on COMT

StudyGeneDrugResultsQuality (0–31)Sample size
Benedetti et al.132COMTParoxetineRs4680 Met/Met ↑ response, Met/Val ↑↓ response, Val/Val ↓ response1755
Leuchter et al.133COMTPlaceboRs4680 Met/Met ↓ placebo response15132
Tsai et al.130COMTFluoxetineMales rs4680 Met carriers ↑ response16334
Perlis et al.134COMTDuloxetiners165599 GG, rs165774 GG, rs174696 CC ↑ response13102
Baune et al.131COMTVariousRs4680 Met/Met ↑ response18256
Yoshida et al.129COMTMilnacipramRs4680 Met/Met ↑ faster therapeutic effect1881
Hu et al.135COMTBupropionrs6277 TC genotype ↑ weight gain
No association with body mass index or weight change
16283
Arias et al.122COMTVariousSmall effect on citalopram treatment result18346
Szegedi et al.128COMTMirtazapine, paroxetineRs4680 ↑ mirtazapine response13102
  • ↑= positive association; ↓ = negative association.